CI Investments Inc’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $210M | Sell |
428,160
-119,627
| -22% | -$64.9M | 1.02% | 18 |
|
|
2025
Q4 | $317M | Sell |
547,787
-64,098
| -10% | -$36.2M | 1.39% | 12 |
|
|
2025
Q3 | $297M | Buy |
611,885
+83,388
| +16% | +$38.8M | 1.08% | 13 |
|
|
2025
Q2 | $214M | Buy |
528,497
+131,509
| +33% | +$55M | 0.8% | 23 |
|
|
2025
Q1 | $198M | Buy |
396,988
+21,349
| +6% | +$11.6M | 0.83% | 19 |
|
|
2024
Q4 | $195M | Buy |
375,639
+172,946
| +85% | +$95.1M | 0.74% | 22 |
|
|
2024
Q3 | $125M | Sell |
202,693
-23,628
| -10% | -$14M | 0.48% | 46 |
|
|
2024
Q2 | $125M | Sell |
226,321
-11,010
| -5% | -$6.31M | 0.49% | 39 |
|
|
2024
Q1 | $138M | Sell |
237,331
-75,939
| -24% | -$42.6M | 0.55% | 34 |
|
|
2023
Q4 | $166M | Sell |
313,270
-140,098
| -31% | -$67.8M | 0.86% | 29 |
|
|
2023
Q3 | $229M | Buy |
453,368
+1,844
| +0.4% | +$983K | 1.28% | 17 |
|
|
2023
Q2 | $236M | Buy |
451,524
+21,195
| +5% | +$11.4M | 1.19% | 20 |
|
|
2023
Q1 | $248M | Sell |
430,329
-32,566
| -7% | -$18.4M | 1.25% | 17 |
|
|
2022
Q4 | $255M | Buy |
462,895
+20,656
| +5% | +$10.9M | 1.29% | 15 |
|
|
2022
Q3 | $224M | Buy |
442,239
+35,095
| +9% | +$19.6M | 1.16% | 16 |
|
|
2022
Q2 | $221M | Buy |
407,144
+93,665
| +30% | +$51.6M | 1.03% | 23 |
|
|
2022
Q1 | $185M | Buy |
313,479
+20,276
| +7% | +$11.6M | 0.68% | 35 |
|
|
2021
Q4 | $196M | Sell |
293,203
-6,377
| -2% | -$3.98M | 0.68% | 37 |
|
|
2021
Q3 | $171M | Buy |
299,580
+177,346
| +145% | +$97.3M | 0.64% | 39 |
|
|
2021
Q2 | $61.7M | Sell |
122,234
-141,267
| -54% | -$66.7M | 0.23% | 118 |
|
|
2021
Q1 | $120M | Sell |
263,501
-115,009
| -30% | -$54.9M | 0.51% | 58 |
|
|
2020
Q4 | $176M | Sell |
378,510
-32,108
| -8% | -$15.1M | 0.78% | 36 |
|
|
2020
Q3 | $181M | Buy |
410,618
+76,420
| +23% | +$31.6M | 0.9% | 28 |
|
|
2020
Q2 | $121M | Buy |
334,198
+34,417
| +11% | +$11.5M | 0.65% | 39 |
|
|
2020
Q1 | $85M | Sell |
299,781
-24,478
| -8% | -$7.72M | 0.52% | 56 |
|
|
2019
Q4 | $105M | Sell |
324,259
-9,773
| -3% | -$2.96M | 0.54% | 64 |
|
|
2019
Q3 | $97.3M | Buy |
334,032
+54,031
| +19% | +$15.5M | 0.5% | 63 |
|
|
2019
Q2 | $82.2M | Sell |
280,001
-356,791
| -56% | -$98.3M | 0.46% | 70 |
|
|
2019
Q1 | $174M | Buy |
636,792
+135,686
| +27% | +$33.8M | 0.98% | 30 |
|
|
2018
Q4 | $112M | Buy |
501,106
+10,266
| +2% | +$2.41M | 0.72% | 46 |
|
|
2018
Q3 | $120M | Sell |
490,840
-113,800
| -19% | -$26.2M | 0.9% | 31 |
|
|
2018
Q2 | $125M | Sell |
604,640
-20,980
| -3% | -$4.45M | 0.98% | 31 |
|
|
2018
Q1 | $129M | Sell |
625,620
-44,322
| -7% | -$9.3M | 1.49% | 17 |
|
|
2017
Q4 | $127M | Buy |
669,942
+21,697
| +3% | +$4.16M | 1.3% | 23 |
|
|
2017
Q3 | $123M | Sell |
648,245
-119,755
| -16% | -$21.7M | 1.2% | 27 |
|
|
2017
Q2 | $134M | Buy |
768,000
+70,200
| +10% | +$11.8M | 1.45% | 19 |
|
|
2017
Q1 | $107M | Sell |
697,800
-181,700
| -21% | -$27.8M | 1.22% | 26 |
|
|
2016
Q4 | $124M | Sell |
879,500
-32,950
| -4% | -$4.86M | 1.36% | 20 |
|
|
2016
Q3 | $145M | Buy |
912,450
+89,150
| +11% | +$13.7M | 1.58% | 12 |
|
|
2016
Q2 | $122M | Sell |
823,300
-19,700
| -2% | -$2.91M | 1.38% | 18 |
|
|
2016
Q1 | $119M | Sell |
843,000
-40,900
| -5% | -$5.48M | 1.52% | 19 |
|
|
2015
Q4 | $125M | Sell |
883,900
-173,600
| -16% | -$23.2M | 1.6% | 18 |
|
|
2015
Q3 | $129M | Sell |
1,057,500
-33,300
| -3% | -$4.34M | 1.68% | 15 |
|
|
2015
Q2 | $142M | Buy |
1,090,800
+15,500
| +1% | +$2.02M | 1.56% | 16 |
|
|
2015
Q1 | $144M | Sell |
1,075,300
-2,600
| -0.2% | -$335K | 1.52% | 16 |
|
|
2014
Q4 | $135M | Sell |
1,077,900
-31,700
| -3% | -$3.85M | 1.53% | 17 |
|
|
2014
Q3 | $135M | Buy |
1,109,600
+159,300
| +17% | +$19.4M | 1.41% | 18 |
|
|
2014
Q2 | $112M | Buy |
950,300
+285,200
| +43% | +$33.6M | 1.11% | 29 |
|
|
2014
Q1 | $80M | Buy |
+665,100
| New | +$79.1M | 0.84% | 38 |
|
Other funds holding TMO
VCM
CI Investments Inc's TMO Position: Q1 2026 in Review
CI Investments Inc reduced its Thermo Fisher Scientific (TMO) stake by 22% in Q1 2026, selling an estimated $64.9M and leaving 428,160 shares worth $210M. The position accounts for 1.02% of the portfolio, ranked #18.
CI Investments Inc first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $317M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- CI Investments Inc held 428,160 shares of Thermo Fisher Scientific worth $210M as of Q1 2026.
- CI Investments Inc sold 119,627 Thermo Fisher Scientific shares in Q1 2026, an estimated $64.9M.
- Thermo Fisher Scientific made up 1.02% of CI Investments Inc's portfolio in Q1 2026, its #18 holding.
- CI Investments Inc first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
- CI Investments Inc's Thermo Fisher Scientific position peaked at $317M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.